Skip to main content
RocheCertification

Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large...

Source: Autobound Signal API · 87 signals tracked for Roche · updated

Get Roche's live signals in Claude or ChatGPT, or by API

AskWhat changed at Roche this week? Use Autobound signals for roche.com.

What happened

Roche received the CE Mark for its cobas smart e immunoanalyser platform.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Basel, 27 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it has received the CE Mark for its cobas smart e immunoanalyser, a compact, standalone platform engineered to deliver reliable testing with a planned menu of over 100 high-medical-value assays. 1,2 As the latest offering in Roche's industry-leading cobas immunoassay systems portfolio, the platform bridges critical operational gaps across health systems by fitting central-laboratory precision into a footprint under one square meter. This enables decentralised sites to manage diverse testing demands directly in-house. With reaction times of 18 minutes or less across more than 90% of Roche immunoassays, local facilities can help reduce diagnostic turnaround times. 1,2

globenewswire.com/news-release/2026/10/27/3388685/0/en/roche-receives...Read the full source

Extracted by Autobound

From the Signal API record
Event
Certification

What this signalsA new certification often shows a push toward larger or regulated customers.

Recognition
CE Mark
Takes effect
Oct 27, 2026
Location
Basel, Basel-Stadt, Switzerland

The full record

From the Signal API record

Details

Ticker
SIX:RO

Extraction

Confidence
95%
Detected
Oct 27, 2026
signal_type
news
signal_subtype
achieves_certification

Use this data

Get every certification signal for Roche and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Roche this week?”

  2. Send it to your own tools

    The Signal API returns certification signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/5f107d05-6d5d-bf1a-7b83-fb1f6fdac116 returns this record as JSON. POST /v1/companies/enrich returns every signal for roche.com.

{
  "signal_id": "5f107d05-6d5d-bf1a-7b83-fb1f6fdac116",
  "signal_type": "news",
  "signal_subtype": "achieves_certification",
  "detected_at": "2026-10-27T06:00:00+00:00",
  "company": {
    "name": "Roche",
    "domain": "roche.com"
  },
  "data": {
    "url": "https://www.globenewswire.com/news-release/2026/10/27/3388685/0/en/roche-receives-ce-mark-for-cobas-smart-e-immunoanalyser-completing-a-portfolio-that-brings-central-lab-precision-to-healthcare-settings-ranging-from-small-clinics-to-large-hospital.html",
    "title": "Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories",
    "ticker": "SIX:RO",
    "excerpt": "Basel, 27 October 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it has received the CE Mark for its cobas smart e immunoanalyser, a compact, standalone platform engineered to deliver reliable testing with a planned menu of over 100 high-medical-value assays. 1,2 As the latest offering in Roche’s industry-leading cobas immunoassay systems portfolio, the platform bridges critical operational gaps across health systems by fitting central-laboratory precision into a footprint under one square meter. This enables decentralised sites to manage diverse testing demands directly in-house. With reaction times of 18 minutes or less across more than 90% of Roche immunoassays, local facilities can help reduce diagnostic turnaround times. 1,2",
    "summary": "Roche received the CE Mark for its cobas smart e immunoanalyser platform.",
    "location": "Basel, Switzerland",
    "planning": false,
    "confidence": 0.95,
    "recognition": "CE Mark",
    "published_at": "2026-10-27T06:00:00Z",
    "location_data": [
      {
        "city": "Basel",
        "state": "Basel-Stadt",
        "region": "Western Europe",
        "country": "Switzerland",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-10-27",
    "article_sentence": "Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it has received the CE Mark for its cobas smart e immunoanalyser, a compact, standalone platform engineered to deliver reliable testing with a planned menu of over 100 high-medical-value assays."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.